Scientists developed an AI ‘fingerprint’ technology to evaluate cancer cell responses to drugs, potentially halving delivery times. This advancement, leveraging machine learning algorithms, can transform drug efficacy testing, impacting pharmaceutical companies and patient care globally. The approach emphasizes rapid, precise drug response profiling for more effective cancer therapies.

Read More:

• 🔗 medicalxpress.com